Please notice!
This website uses cookies to provide necessary site functionality and improve your online experience. By using this website, you agree to the use of cookies as outlined in the
Privacy Statement
.

As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is
committed to providing our customers around the world with the highest quality products.
In addition to direct selling in more than 20 countries in North America, Europe and
Asia/Pacific, Miltenyi Biotec also provides support for our customers through an
extensive distributor network covering dozens of additional countries.

As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is
committed to providing our customers around the world with the highest quality products.
In addition to direct selling in more than 20 countries in North America, Europe and
Asia/Pacific, Miltenyi Biotec also provides support for our customers through an
extensive distributor network covering dozens of additional countries.

Background information

Interleukin 33 (IL-33) is a cytokine belonging to the IL-1 family. Similarly to other IL-1 family members, IL-33 exists in both an un-cleaved (full-length) and a cleaved form, although the proteins responsible of IL-33 maturation are still under investigation. IL-33 is expressed by several cell types including epithelial cells, endothelial cells, and fibroblasts, and binds a specific receptor, also known as IL1RL1, which is expressed on Tʜ2 cells and mast cells. Signaling via IL1RL1 involves receptor accessory protein (IL1RAP) and leads to the expression of type 2 cytokines, such as IL-4, IL-5, IL-13. Via enhancing the activation of Tʜ2 cells, mast cells, and eosinophils, IL-33 sustains the humoral response and contributes to adverse Tʜ2 reactions, such as dermatitis, asthma, and allergies. Besides its primary involvement in the immune system modulation, IL-33 is also expressed in blood epithelium and smooth muscle and plays a role in bone protection. It is unclear whether also the immature form of IL-33 could be biologically active after release, such as during necrosis. Moreover, it was suggested that the full length protein could co-localize in the nucleus and act as transcriptional factor. Recombinant Human IL-33 corresponds to the mature form of human IL-33.

Quality description

Research-grade

cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade

cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific certificates of analysis are available on request (macstec@miltenyibiotec.de).